Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.52 -0.32 (-1.07%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Total Liabilities (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) posted Total Liabilities of $139.39 million for the quarter ended Mar 31, 2026, down 89.6% from $1.34 billion a year earlier and down 29.8% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Total Liabilities (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Total Liabilities came in at $192.8 million, down 85.6% from the prior year.

  • Annual Total Liabilities has declined for six consecutive years, with a five-year compound annual growth rate of -43.9% (years ended Dec 2020 to Dec 2025).
  • In prior years, Lakefront Biotherapeutics' Total Liabilities was $1.34 billion in the year ended Dec 31, 2024 (-20.2%), $1.68 billion in the year ended Dec 31, 2023 (-27.8%), $2.33 billion in the year ended Dec 31, 2022 (-22.9%) and $3.02 billion in the year ended Dec 31, 2021 (-13.3%).
  • The figure for the quarter ended Mar 31, 2026 stands as the lowest quarterly Total Liabilities since the quarter ended Jun 30, 2018.
  • On a year-over-year basis, Total Liabilities has declined in each of the last three quarters, with an average decline of 42.2% over the last six quarters.
  • Across the past five years, year-over-year decline in Total Liabilities ran from 1.7% in the quarter ended Jun 30, 2021 to 89.6% in the quarter ended Mar 31, 2026.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $198.64 million (quarter ended Dec 31, 2025), $1.24 billion (quarter ended Sep 30, 2025) and $1.33 billion (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Lakefront Biotherapeutics 1.97 Bn 1.97 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 139.39 Mn
Dec 31, 2025 198.64 Mn
Sep 30, 2025 1.24 Bn
Jun 30, 2025 1.33 Bn
Mar 31, 2025 1.34 Bn
Dec 31, 2024 1.32 Bn
Sep 30, 2024 1.44 Bn
Mar 31, 2024 1.59 Bn
Dec 31, 2023 1.68 Bn
Sep 30, 2023 1.99 Bn
Mar 31, 2023 2.22 Bn
Dec 31, 2022 2.25 Bn
Mar 31, 2022 2.75 Bn
Dec 31, 2021 2.92 Bn
Jun 30, 2021 3.33 Bn
Dec 31, 2020 3.63 Bn
Jun 30, 2020 3.39 Bn
Mar 31, 2020 3.48 Bn
Dec 31, 2019 3.53 Bn
Sep 30, 2019 3.69 Bn
API Access

Lakefront Biotherapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=LKFT&period=max&api_key=YOUR_API_KEY